
10X Genomics (TXG) Stock Forecast & Price Target
10X Genomics (TXG) Analyst Ratings
Bulls say
10x Genomics is a life science technology company with a strong outlook due to its innovative product offerings and expanding base of applications. It has experienced double-digit growth in spatial consumables revenue and has a competitive advantage in the market. While there are risks from competition in the single cell market, the company is well-positioned for growth and has a positive outlook for the future.
Bears say
10x Genomics is facing pressure in both its product sales and instrument placements, with a decline in expected 2026 revenue guidance and persistent capex hesitancy leading to flat Chromium consumables sales for the year. Additionally, increased competition and changes in commercial leadership pose risks for the company, potentially limiting its growth and profitability in the future.
This aggregate rating is based on analysts' research of 10X Genomics and is not a guaranteed prediction by Public.com or investment advice.
10X Genomics (TXG) Analyst Forecast & Price Prediction
Start investing in 10X Genomics (TXG)
Order type
Buy in
Order amount
Est. shares
0 shares